Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions
Julia Obergasteiger, Giulia Frapporti, Giulia Lamonaca, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 73
“LRRK2: Autophagy and Lysosomal Activity”
Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 114
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
Shirley Yin-Yu Pang, Rachel Lo, Philip Wing‐Lok Ho, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 47
New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin
Konstantin Senkevich, Uladzislau Rudakou, Ziv Gan‐Or
Neuropharmacology (2021) Vol. 202, pp. 108822-108822
Closed Access | Times Cited: 54
The Emerging Roles of Autophagy in Human Diseases
Yuchen Lei, Daniel J. Klionsky
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1651-1651
Open Access | Times Cited: 46
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology
Julia Obergasteiger, Anne-Marie Castonguay, Sara Pizzi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Adamantios Mamais, Anwesha Sanyal, Austin Fajfer, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 163-173
Open Access | Times Cited: 6
Decoding mitochondrial quality control mechanisms: Identifying treatment targets for enhanced cellular health
Nitu L. Wankhede, Spandana Rajendra Kopalli, Mrunali D. Dhokne, et al.
Mitochondrion (2024) Vol. 78, pp. 101926-101926
Closed Access | Times Cited: 6
α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson’s disease
Annie J. Zalon, Drew J. Quiriconi, Caleb Pitcairn, et al.
The Neuroscientist (2024) Vol. 30, Iss. 5, pp. 612-635
Closed Access | Times Cited: 5
Concurrent Optimizations of Efficacy and Blood–Brain Barrier Permeability in New Macrocyclic LRRK2 Inhibitors for Potential Parkinson’s Disease Therapeutics
Kewon Kim, Ahyoung Jang, Ho‐Chul Shin, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7647-7662
Closed Access | Times Cited: 5
Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
Di Hu, Zunren Liu, Xin Qi
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 30
LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress‐Induced Cellular Senescence in Neuronal Cells
Dong Hwan Ho, Daleum Nam, Mi Kyoung Seo, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 24
WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes
Rebecca L. Wallings, Laura P. Hughes, Hannah A. Staley, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner
Elżbieta Kania, Jaclyn S. Long, David G. McEwan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 10
Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells
Doyeong Kim, Sang‐Min Park, Seoyoung Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Autophagy Process in Parkinson’s Disease Depends on Mutations in the GBA1 and LRRK2 Genes
Anastasia Bezrukova, Katerina Basharova, Anton Emelyanov, et al.
Biochemical Genetics (2025)
Closed Access
Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease
Ga Hyun Park, Joon Hyung Park, Kwang Chul Chung
BMB Reports (2021) Vol. 54, Iss. 12, pp. 592-600
Open Access | Times Cited: 21
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway
Federica Albanese, Chiara Domenicale, Mattia Volta, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 621-632
Closed Access | Times Cited: 15
Tissue specific LRRK2 interactomes reveal a distinct striatal functional unit
Yibo Zhao, Nikoleta Vavouraki, Ruth C. Lovering, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 1, pp. e1010847-e1010847
Open Access | Times Cited: 9
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo
Federica Albanese, Daniela Mercatelli, Luca Finetti, et al.
Neurobiology of Disease (2021) Vol. 159, pp. 105487-105487
Open Access | Times Cited: 20
High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification
Aurore Vuidel, Loïc Cousin, Beatrice Weykopf, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 10, pp. 2349-2364
Open Access | Times Cited: 14
Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
Ga Hyun Park, Joon Hyung Park, Kwang Chul Chung
PubMed (2021) Vol. 54, Iss. 12, pp. 592-600
Closed Access | Times Cited: 18
Increased Levels of the Parkinson’s Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status
Francesca Di Leva, Michele Filosi, Lisa J. Oyston, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1984-1984
Open Access | Times Cited: 7
LRRK2 along the Golgi and lysosome connection: a jamming situation
Giovanni Piccoli, Mattia Volta
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2063-2072
Open Access | Times Cited: 15
Roles of neuronal lysosomes in the etiology of Parkinson's disease
Mattia Volta
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1981-1983
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top